Financials Positive

2026-08-13 17:50

- Q1 FY26-27 Consolidated Revenue from Operations ₹125.53Cr vs ₹116.90Cr (▲7% YoY) - Profit Before Tax ₹32.25Cr vs ₹20.29Cr (▲59% YoY) - PAT ₹24.85Cr vs ₹15.75Cr (▲58% YoY) - Recommended a final dividend of ₹0.10 per equity share for FY26.

Governance Neutral

2026-08-13 17:10

CRITICAL RED FLAG DETECTED

- Mr. Vijay Shankarlal Bankda has resigned as Managing Director and Director of Syncom Formulation (India) Limited, effective August 11, 2026. - The company stated the resignation is due to leadership transition and effective succession planning. - Mr. Bankda confirmed his resignation is voluntary and not due to any disagreement with the Board or management.

Governance Negative

2026-08-13 17:07

CRITICAL RED FLAG DETECTED

- Mr. Kedarmal Shankarlal Bankda, Founder & Whole-Time Director, resigned from Syncom Formulations (India) Limited, effective August 11, 2026. - The resignation is voluntary, citing timely succession planning and health and well-being, with no disagreement with the Board or management.

Governance Negative

2026-08-11 19:20

CRITICAL RED FLAG DETECTED

- Shri Kedarmal Shankarlal Bankda resigned as Whole-time Director, effective August 11, 2026. - Shri Vijay Shankarlal Bankda resigned as Managing Director, effective August 11, 2026. - Shri Rahul Vijay Bankda resigned as Chief Financial Officer (KMP), effective August 11, 2026. - Smt. Rinki Ankit Bankda appointed as Whole Time Director, effective August 12, 2026, subject to shareholder approval. - Shri Rahul Vijay Bankda appointed as Managing Director, effective August 12, 2026, subject to shareholder approval. - Shri Ankur Vijay Bankda redesignated as Chief Financial Officer (CFO), effective August 12, 2026. - Smt. Ruchi Jindal reappointed as Woman Independent Director, effective June 29, 2027, subject to shareholder approval.

Governance Neutral

2026-08-11 19:17

- Providing remote E-Voting facilities for the 38th Annual General Meeting (AGM). - AGM scheduled for 30th September, 2026, at 2:00 p.m. - E-voting period: 27th September, 2026 (9:00 AM) to 29th September, 2026 (5:00 PM). - Cut-off date for e-voting entitlement: 23rd September, 2026.

Governance Neutral

2026-08-11 19:09

- Syncom Formulations (India) Limited appointed M/s M. Goyal & Co. Cost Accountants as Cost Auditor for FY 2026-27. - M/s Bansal & Agrawal, Chartered Accountants, were appointed as Internal Auditor for FY 2026-27. - These appointments were approved by the Board on August 11, 2026.

Financials Positive

2026-08-11 18:54

- Q1 FY27 Consolidated Revenue ₹125.53Cr vs ₹116.90Cr (▲7.4% YoY) - EBITDA ₹26.21Cr vs ₹15.85Cr (▲65.4% YoY) - PAT ₹24.85Cr vs ₹15.75Cr (▲57.7% YoY) - EBITDA Margin 20.9% vs 13.6% (▲730bps)

Financials Positive

2026-08-11 18:12

- Record Date: September 23, 2026, for a 10% (₹0.10 per share) final dividend for FY 2025-26, subject to AGM approval. - The 38th Annual General Meeting will be held on September 30, 2026, at 2:00 P.M. via video conferencing.

Governance Positive

2026-08-11 18:09

- Record Date for final dividend of 10% (₹0.10 per share) for FY 2025-26 is September 23, 2026. - The 38th Annual General Meeting (AGM) will be held on September 30, 2026, at 2:00 PM via Video Conferencing/OAVM to approve the dividend.

Governance Neutral

2026-08-11 18:06

CRITICAL RED FLAG DETECTED

- Board meeting on Aug 11, 2026, approved Q1 FY27 results and recommended Re. 0.10/- final dividend for FY26. - Noted resignations of Whole-time Director, MD, and CFO; new appointments made for these positions. - The 38th AGM is scheduled for September 30, 2026.

Governance Negative

2026-08-08 14:58

CRITICAL RED FLAG DETECTED

- Mr. Vijay Shankarlal Bankda has resigned as Managing Director and Director of Syncom Formulations (India) Limited. It is effective from August 11, 2026. - He stated the resignation is part of a planned leadership transition and voluntary, with no disagreement.

Governance Neutral

2026-08-08 14:34

CRITICAL RED FLAG DETECTED

- Mr. Rahul Vijay Bankda resigned as Chief Financial Officer (CFO) of Syncom Formulations (India) Limited, effective August 11, 2026. His resignation is for different professional responsibilities and not due to any disagreement. He will continue to be associated with the company in a different capacity.

Governance Neutral

2026-08-08 13:34

CRITICAL RED FLAG DETECTED

- Mr. Kedarmal Shankarlal Bankda resigned as Whole-Time Director, effective August 11, 2026. - Voluntary resignation for succession planning after over five decades of service, not due to disagreement. - Board acknowledged his significant contributions.

Routine Neutral

2026-06-25 13:50

- Trading window for shares of Syncom Formulations (India) Limited will close from July 1, 2026. - It will remain closed until 48 hours after the declaration of Un-Audited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. - This closure is as per SEBI (Prohibition of Insider Trading) Regulations, 2015.

Financials Positive

2026-05-22 18:43

Consolidated Revenue for the year ended March 31, 2026, was ₹48,917.15 Lacs vs ₹46,501.26 Lacs (▲5.20% YoY), EBITDA was ₹7,746.69 Lacs vs ₹5,413.75 Lacs (▲43.10% YoY), and PAT was ₹7,643.80 Lacs vs ₹4,943.46 Lacs (▲54.62% YoY). EBITDA Margin expanded to 15.84% vs 11.64% (▲420bps). The auditor has issued an unmodified opinion on the financial results.

Business Update Positive

2026-05-04 18:05

Syncom Formulations (India) Limited disclosed the successful acquisition of a commercial property, the entire 7th Floor of Trade Star, Andheri-Kurla Road, Mumbai, from HDFC Bank Ltd. The company paid a total consideration of Rs. 57,26,00,000/- (Rupees 57.26 Crores) for the acquisition.

Routine Neutral

2026-04-07 13:55

Syncom Formulations (India) Limited submitted the Regulation 74(5) SEBI (Depository and Participants) Regulations, 2018 compliance certificate for the quarter ended March 31, 2026. The RTA confirmed timely processing of dematerialization requests and cancellation of physical certificates.

Ownership Neutral

2026-04-06 17:55

Syncom Formulations (India) Limited submitted its yearly disclosure under SEBI (SAST) Regulations 31(4) for the financial year ended March 31, 2026. The promoters and Persons Acting in Concert declared no new encumbrances in the company's securities beyond those already disclosed.

Routine Neutral

2026-03-25 16:55

Syncom Formulations (India) Limited announced the closure of its trading window from April 1, 2026, until 48 hours after the declaration of Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2026, to prevent insider trading.

Financials Neutral

2026-02-12 16:48

CRITICAL RED FLAG DETECTED

Consolidated Revenue ₹11,514.06 Lakhs vs ₹12,753.32 Lakhs (▼9.72% YoY), EBITDA ₹2,671.14 Lakhs vs ₹1,876.79 Lakhs (▲42.33% YoY), PAT ₹1,890.81 Lakhs vs ₹1,300.20 Lakhs (▲45.42% YoY). EBITDA Margin 23.20% vs 14.71% (▲849bps). The company has received an intimation for rejection of appeal and demand of ₹1.42 Cr towards ineligible Input Tax Credit and penalty, which it plans to contest.

SYNCOMF

Syncom Formulations (India) Limited

Price Chart

Filing History

Unlock Full History